Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Bazemore, Robert Jr.. Insider active across 1 company, notably Eupraxia Pharmaceuticals Inc.. In total, 5 disclosures have been logged. History available since 25 June 2026. The latest transaction was disclosed on 25 June 2026 (50 - Grant of options). Regulator: SEDI. All data is openly available.
5 of 5 declarations
Robert Jr. Bazemore is a declarant linked to Eupraxia Pharmaceuticals Inc., where he is 4 - Director of Issuer. He has 5 filings in total, and the sampled recent filings cover the period from 2026-06-30 to 2026-06-30, with buy volume of EUR 0 and sell volume of EUR 0; the modal transaction nature is 00 - Opening Balance-Initial SEDI Report.